Latest Annual Reports
by Mike Gee
23 May 2026









































Aldel Financial II Inc.
REVENUE
N/A
INCOME
$9,225,582
EMPLOYEES
N/A
CUSTOMERS
N/A
A Cayman Islands‑domiciled blank check company (SPAC) formed to pursue a financial‑services‑focused business combination in North America; completed a $230.0 million IPO and held approximately $243.0 million in a trust account as of December 31, 2025.
View Company PageFiled: 2026-03-25
Calisa Acquisition Corp
REVENUE
N/A
INCOME
$245,454
409.05%
EMPLOYEES
N/A
CUSTOMERS
N/A
A special purpose acquisition company (SPAC) that completed an IPO raising $60,000,000, holds approximately $60.43 million in assets held in trust and reported total assets of $61.02 million and net income of $245,454 for the year ended 2025.
View Company PageFiled: 2026-03-25
DT Cloud Star Acquisition Corp
REVENUE
N/A
INCOME
$2,132,715
78.68%
EMPLOYEES
3
CUSTOMERS
N/A
DTSQ is a Cayman Islands‑domiciled special purpose acquisition company (SPAC) formed to effect a merger, share exchange, asset acquisition or similar business combination across industries and geographies.
View Company PageFiled: 2026-03-25
AB Private Lending Fund
REVENUE
$30,043,625
39.26%
INCOME
$12,085,915
23.89%
EMPLOYEES
N/A
CUSTOMERS
N/A
AB Private Lending Fund is an externally managed, non‑diversified closed‑end Business Development Company that primarily originates and invests in senior secured private credit for U.S. middle‑market companies, with a minority allocation to syndicated loans and high‑yield bonds.
View Company PageFiled: 2026-03-25
Concord Acquisition Corp II
REVENUE
N/A
INCOME
$556,003
172.58%
EMPLOYEES
N/A
CUSTOMERS
N/A
Unnamed blank-check (SPAC) company with a Trust Account and significant redemption activity; reports no operating revenues and recorded net income of $556,003 in 2025 (net loss of $766,076 in 2024), largely driven by fair value adjustments and financing-related items.
View Company PageFiled: 2026-03-25
CATO CORP
REVENUE
$653,812,000
0.62%
INCOME
-$5,909,000
67.28%
EMPLOYEES
N/A
CUSTOMERS
N/A
Publicly traded company with mining operations (presence of Mine Safety Disclosures), physical properties and facilities, and cybersecurity governance; reported 2026 revenues of $653,812,000 and a net loss of $5,909,000 (2025: revenues $649,806,000, net loss $18,057,000); customer and employee counts were not disclosed in the provided statements.
View Company PageFiled: 2026-03-25
Chewy, Inc.
REVENUE
$12,601,500,000
6.24%
INCOME
$222,800,000
-43.26%
EMPLOYEES
18,000
CUSTOMERS
N/A
Chewy, Inc. is a large online pet products and services platform serving the U.S. and Canada, offering ~190,000 products, private brands, pharmacy, telehealth, insurance and veterinary clinic services, and a broad fulfillment and technology infrastructure.
View Company PageFiled: 2026-03-25
CoJax Oil & Gas Corp
REVENUE
$963,621
-0.83%
INCOME
-$1,109,209
31.10%
EMPLOYEES
2
CUSTOMERS
N/A
CoJax Oil and Gas Corporation is an early-stage Gulf States-focused oil and gas company that acquires and develops producing and underexploited crude oil and natural gas properties and relies on contractor-based operations to improve cash flow through recompletions, infill drilling and operational efficiencies.
View Company PageFiled: 2026-03-25
BeyondSpring Inc.
REVENUE
N/A
INCOME
-$14,217,000
14.83%
EMPLOYEES
44
CUSTOMERS
N/A
BeyondSpring Inc. is a clinical-stage global biopharmaceutical company developing cancer therapies led by plinabulin and supplemented by early-stage immune agents and an equity stake in SEED Therapeutics (molecular glue/TPD), headquartered in Florham Park, New Jersey with offices in China.
View Company PageFiled: 2026-03-25
Braze, Inc.
REVENUE
$738,182,000
24.40%
INCOME
-$130,786,000
-25.70%
EMPLOYEES
1,988
CUSTOMERS
2,609
Braze is a customer engagement platform that enables brands to deliver cross-channel, real-time, personalized interactions by activating first‑party data and AI-driven orchestration.
View Company PageFiled: 2026-03-25
ATOSSA THERAPEUTICS, INC.
REVENUE
N/A
INCOME
-$34,800,000
-36.45%
EMPLOYEES
N/A
CUSTOMERS
N/A
Clinical-stage biopharmaceutical company developing oral (Z)-endoxifen for breast cancer indications (risk reduction and neoadjuvant settings) and select rare pediatric diseases.
View Company PageFiled: 2026-03-25
DYADIC INTERNATIONAL INC
REVENUE
$3,090,345
-11.59%
INCOME
-$7,364,628
-26.78%
EMPLOYEES
5
CUSTOMERS
14
Dyadic Applied BioSolutions is a Jupiter, Florida–based biotechnology company that develops, manufactures, and commercializes animal-free recombinant proteins and enzymes for life sciences, food & nutrition, and bio-industrial markets using its proprietary C1 and Dapibus microbial expression platforms.
View Company Page